Associations between comorbidities, their treatment and survival in patients with interstitial lung diseases – a claims data analysis

被引：0
|
作者：
Larissa Schwarzkopf
Sabine Witt
Julia Waelscher
Markus Polke
Michael Kreuter
机构：
[1] Comprehensive Pneumology Center Munich (CPC-M),Helmholtz Zentrum München – German Research Center for Environmental Health (GmbH), Institute of Health Economics and Health Care Management
[2] Member of the German Center for Lung Research (DZL),Center for Interstitial and Rare Lung Diseases, Pneumology and Respiratory Critical Care Medicine, Thoraxklinik
[3] University of Heidelberg,undefined
[4] Translational Lung Research Center Heidelberg (TLRC),undefined
[5] Member of the German Center for Lung Research (DZL),undefined
来源：
Respiratory Research | / 19卷
关键词：
Administrative data; Pharmaceutical management; Drugs; Mortality; Diffuse parenchymal lung disease; Multi-morbidity; Germany; Statutory Health Insurance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Autoimmune comorbidities in patients with metastatic melanoma: a retrospective analysis of us claims data
    Qiufei Ma
    Mark Shilkrut
    Zhongyun Zhao
    Minming Li
    Nicolas Batty
    Beth Barber
    BMC Cancer, 18
  • [22] Treatment in diffuse interstitial lung diseases
    Kayacan, Oya
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2005, 53 (02): : 190 - 199
  • [23] Volumetric texture analysis in the characterisation of interstitial lung diseases in lung transplant patients
    Gentili, Francesco
    Mazzei, Maria Antonietta
    Nardone, Valerio
    Fossi, Antonella
    Bennett, David
    Spina, Donatella
    Tini, Paolo
    Mazzei, Francesco Giuseppe
    Pirtoli, Luigi
    Rottoli, Paola
    Volterrani, Luca
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [24] Treatment and comorbidities of multiple sclerosis in an employed population in Japan: analysis of health claims data
    Ogino, Mieko
    Shiozawa, Aki
    Ota, Hiroyuki
    Okamoto, Shuichi
    Hiroi, Shinzo
    Kawachi, Izumi
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2018, 8 (02) : 97 - 103
  • [25] REAL WORLD TREATMENT AND SURVIVAL OF PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER: AN ANALYSIS USING JAPANESE CLAIMS DATA
    Ghiani, M.
    Bruellinger, L.
    Mueller, S.
    Wilke, T.
    VALUE IN HEALTH, 2019, 22 : S534 - S534
  • [26] CARDIOVASCULAR COMORBIDITIES IN LUNG CANCER PATIENTS: TREATMENT-SPECIFIC EFFECTS ON SURVIVAL
    Kravchenko, J.
    Berry, M. F.
    Arbeev, K. G.
    Akushevich, I.
    GERONTOLOGIST, 2014, 54 : 122 - 122
  • [27] Unclassifiable interstitial lung diseases: Clinical characteristics and survival
    Hyldgaard, Charlotte
    Bendstrup, Elisabeth
    Wells, Athol U.
    Hilberg, Ole
    RESPIROLOGY, 2017, 22 (03) : 494 - 500
  • [28] Prevalence of ocular comorbidities in patients with multiple myeloma: An analysis of US claims data.
    Ailawadhi, Sikander
    Ma, Qiufei
    Jalbert, Jessica J.
    Zhou, Mo
    Zhou, Zheng-Yi
    Downes, Nathaniel
    Briggs, Allison
    Chi, Lei
    Hampp, Christian
    Song, Xue
    Noguera-Troise, Irene
    Weyne, Jonathan
    Kroog, Glenn Scott
    Rodriguez-Lorenc, Karen
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [29] LUNG ULTRASOUND IN PATIENTS WITH SECONDARY INTERSTITIAL LUNG DISEASES
    Kirillova, E.
    Shamsutdinova, N.
    Nurullina, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 502 - 503
  • [30] Effectiveness of Lung Transplantation in Patients With Interstitial Lung Diseases
    Stacel, Tomasz
    Necki, Miroslaw
    Antonczyk, Remigiusz
    Latos, Magdalena
    Urlik, Maciej
    Kosciolek, Joanna
    Kordylewska-Kubus, Angelika
    Litewka, Joanna
    Przybylowski, Piotr
    Zawadzki, Fryderyk
    Wajda-Pokrontka, Marta
    Pyrc, Krzysztof
    Zembala, Marian
    Ochman, Marek
    TRANSPLANTATION PROCEEDINGS, 2020, 52 (07) : 2143 - 2148
12345